It's either a quiet period, Dr. Jay and team have lost their willingness to communicate with investors, or, since ESMO, nothing has happened worthy of a press release. The last two make no sense in light of the past 20 months. What was the purposet of working so diligently to have the clinical hold removed by the FDA to do nothing.